Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$287,423
-$29,643 QoQ
Shares Held
2,275
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,672
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAIRS & POWER INC holds $516,794,572 across 8 Drug Manufacturers - General names. GILD ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
322,129 | $386,371,218 | |
| 2 | JNJ |
Johnson & Johnson
|
423,010 | $107,431,849 | |
| 3 | ABBV |
AbbVie Inc.
|
44,702 | $11,248,811 | |
| 4 | MRK |
Merck & Co., Inc.
|
51,519 | $6,620,191 | |
| 5 | AMGN |
Amgen Inc
|
4,924 | $1,783,078 | |
| 6 | PFE |
Pfizer Inc
|
67,679 | $1,629,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,684 | $1,422,292 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
2,275 | $287,423 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,423 | 2,275 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $317,066 | 2,275 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $279,233 | 2,275 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $252,525 | 2,275 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $277,285 | 2,501 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||